ArticleCanadian liver journal2024
Hepatic encephalopathy and driving safety: A survey of patient counseling and regulatory reporting by health care professionals in British Columbia, Canada.
Article in Canadian liver journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hepatic encephalopathy (HE) is a neuropsychiatric syndrome resulting from liver dysfunction, leading to significant cognitive and motor impairments. These impairments can severely affect daily activities, including driving. This research explores the public safety issue of HE and driving safety, focusing on the knowledge and practices of health care professionals. Methods: An electronic survey was distributed across various institutions in British Columbia, Canada, targeting 191 health care professionals, including attending physicians, residents, nurse practitioners, medical students, and fellows from various specialties. The survey assessed the training received, frequency of discussions about driving safety, and actions taken regarding advising patients to stop driving. Results: This study revealed significant gaps in addressing driving safety protocols by health care providers among patients with HE. Only 19.9% of professionals routinely ask their patients about driving, and few engage in specific discussions about driving safety. Internal medicine and gastroenterology specialists, who are most likely to care for patients with HE, reported low practices of screening for and educating about HE and driving safety. Conclusions: The findings underscore the need for increased awareness and proactive discussions among health care providers regarding driving safety in patients with HE. Implementing routine assessments and discussions in HE management protocols can enhance patient safety. Future research should focus on developing standardized guidelines and evaluating the effectiveness of interventions in reducing driving-related risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.